Samsung Biologics Reports Third Quarter 2026 Financial Results
Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion Plant 5 ramp-up and U.S. manufacturing operations contribute to earnings performance Raised 2026 revenue growth guidance to 20% while advancing strategic investments in portfolio and capacity expansion INCHEON, South Korea, Oct. 21, 2026 /PRNewswire/ --...
Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value
64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. More than 10 studies have been selected to highlight the latest findings on HER2- and HER3-targeted antibody-drug conjugates (ADCs) in breast and lung cancers, advancing research on novel targets and exploring...
Homage Launches Esteem AI to Meet Surging Eldercare Demand Across Asia
AI agents prepare the paperwork behind every care visit. Care teams stay in control of the care. SINGAPORE, Oct. 21, 2026 /PRNewswire/ -- Homage, the Singapore-founded home care company, today launched Esteem AI, care management software for home care, aged care and disability support providers. Its AI agents handle the paperwork behind each care visit, giving care managers...
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™
Exclusive co-promotion agreement combines AROA's regenerative tissue technology with Mölnlycke's wound care expertise and commercial reach AUCKLAND, New Zealand, Oct. 21, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, has entered into an exclusive agreement with Mölnlycke Healthcare US to co-promote Endoform™ in U.S. post-acute settings,...
Telix Reports Third Quarter 2026 Financial Performance
MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026). Q3 2026 Highlights Group revenue of US$245 million increased 19% over the prior...
Lunit Highlights AI-Powered Pathology Insights Across Cancer Types at ESMO 2026
Five studies to be presented, with key research examining AI-based biomarker assessment and tumor microenvironment analysis in breast, lung and pancreatic cancers SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that five studies involving its AI-powered pathology...
Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment
Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone payment from Servier. The multi-targets oncology collaboration of both parties, announced in early 2026, carries a total value of up to $888 million with...
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses MORRISVILLE, N.C., Oct. 20, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostics, therapeutics, and precision medicine, today announced Splash & Ripple, a...
Qualityze Earns Frost & Sullivan’s 2026 North American Enabling Technology Leadership Recognition for Life Sciences QMS Software
The company is honored for its Salesforce-native, intelligence-driven platform that combines automation, configurable workflows, and compliance-grade processes to advance quality management in life sciences industry. SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Qualityze, a software company based in Florida, has been honored by Frost & Sullivan's 2026 North American Enabling Technology Leadership Recognition award in the life sciences quality...
G-NiiB GenieBiome Named an Inaugural Hong Kong New Industrialisation Elite Enterprise
Recognition highlights Hong Kong's strengthin university research translation and life and health technology industrialisation HONG KONG, Oct. 20, 2026 /PRNewswire/ -- G–NiiB GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong, has been named one of Hong Kong's inaugural New Industrialisation Elite Enterprises. Conferred by the Innovation, Technology and Industry Bureau of the Government of the...
